Adaptive Biotechnologies (ADPT)
Provides clonoSEQ residual-disease testing and immune-receptor discovery services.
$27.77
vs last close−0.29 (−1.02%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.10
Revenue estimate
$71.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported−$0.23−$0.20−$0.17$0.06−$0.09−$0.13−$0.25Pending
Estimate−$0.27−$0.34−$0.24−$0.18−$0.19−$0.16−$0.13−$0.10
Surprise+14.8%+41.2%+29.2%+133.3%+52.6%+18.8%−87.1%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$47.5M$52.4M$58.9M$94.0M$71.7M$70.9M$71.6MPending
Estimate$46.0M$42.7M$49.4M$64.6M$60.9M$61.0M$65.4M$71.6M
Surprise+3.1%+22.9%+19.2%+45.4%+17.7%+16.2%+9.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.03 | — | — |
| Sep 2028 | $0.01 | — | — |
| Jun 2028 | $0.01 | — | — |
| Mar 2028 | −$0.05 | — | — |
| Dec 2027 | −$0.02 | — | — |
| Sep 2027 | −$0.05 | — | — |
| Jun 2027 | −$0.05 | — | — |
| Mar 2027 | −$0.10 | — | — |
| Dec 2026 | −$0.07 | — | — |
| Nov 2026 | −$0.10 | — | — |
| Jul 2026 | −$0.13 | −$0.25 | −87.1% |
| May 2026 | −$0.16 | −$0.13 | +18.8% |
| Feb 2026 | −$0.19 | −$0.09 | +52.6% |
| Nov 2025 | −$0.18 | $0.06 | +133.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.03 | — | — | $125.7M | — | — | — |
| Sep 2028 | $0.01 | — | — | $110.6M | — | — | — |
| Jun 2028 | $0.01 | — | — | $107.8M | — | — | — |
| Mar 2028 | −$0.05 | — | — | $96.0M | — | — | — |
| Dec 2027 | −$0.02 | — | — | $100.7M | — | — | — |
| Sep 2027 | −$0.05 | — | — | $90.9M | — | — | — |
| Jun 2027 | −$0.05 | — | — | $88.8M | — | — | — |
| Mar 2027 | −$0.10 | — | — | $78.5M | — | — | — |
| Dec 2026 | −$0.07 | — | — | $79.0M | — | — | — |
| Nov 4, 2026 | −$0.10 | — | — | $71.6M | — | — | — |
| Jul 29, 2026 | −$0.13 | −$0.25 | −87.1% | $65.4M | $71.6M | +9.3% | +7.2% |
| May 5, 2026 | −$0.16 | −$0.13 | +18.8% | $61.0M | $70.9M | +16.2% | +4.7% |
| Feb 5, 2026 | −$0.19 | −$0.09 | +52.6% | $60.9M | $71.7M | +17.7% | −4.3% |
| Nov 6, 2025 | −$0.18 | $0.06 | +133.3% | $64.6M | $94.0M | +45.4% | −5.0% |
| Aug 5, 2025 | |||||||
| May 5, 2025 | |||||||
| Feb 12, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 13, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 14, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 15, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 12, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 13, 2019 | |||||||
| Jun 27, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |